Updated Jul 16, 2026
Josephs Paul has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Paul Josephs is the Chief Executive Officer of Lifecore Biomedical, Inc., a company specializing in the development and manufacturing of hyaluronic acid-based products. His leadership role involves overseeing the company's strategic direction and operations.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | F — Tax withholding / forfeiture | 40.4K | $4.57 | $185K |
| 2025-07-08 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | F — Tax withholding / forfeiture | 54.9K | $8.19 | $449K |
| 2025-07-08 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | M — Option exercise | 150.0K | — | |
| 2025-05-20 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | F — Tax withholding / forfeiture | 21.5K | $6.63 | $143K |
| 2024-12-10 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | F — Tax withholding / forfeiture | 11.8K | $7.15 | $84K |
| 2024-12-10 | LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | A — Grant or award | 38.5K | $0.00 |
Paul Josephs is the Chief Executive Officer of Lifecore Biomedical, Inc., a company specializing in the development and manufacturing of hyaluronic acid-based products. His leadership role involves overseeing the company's strategic direction and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Josephs Paul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.